CAR T-cell Therapy Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Abecma, Breyanzi, Carvykti, Kymriah), By Disease Indication (Lymphoma, Leukemia, Multiple Myeloma), By End Use, By Region, And Segment Forecasts
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Market Segmentation
- CAR T-cell Therapy Product Outlook (Revenue, USD Million, 2021 - 2033)
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
- CAR T-cell Therapy Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- CAR T-cell Therapy End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Cancer Treatment Centers
- CAR T-cell Therapy Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- North America CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
- North America CAR T-cell Therapy Disease Market, By Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- North America CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- U.S.
- U.S. CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
- U.S. CAR T-cell Therapy Market, By Disease Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- U.S. CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- U.S. CAR T-cell Therapy Market, By Product
- Canada
- Canada CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
- Canada CAR T-cell Therapy Market, By Disease Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- Canada CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- Canada CAR T-cell Therapy Market, By Product
- North America CAR T-cell Therapy Market, By Product
- Europe
- Europe CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
- Europe CAR T-cell Therapy Market, By Disease Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- Europe CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- UK
- UK CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
- UK CAR T-cell Therapy Market, By Disease Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- UK CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- UK CAR T-cell Therapy Market, By Product
- Germany
- Germany CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
- Germany CAR T-cell Therapy Market, By Disease Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- Germany CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- Germany CAR T-cell Therapy Market, By Product
- Europe CAR T-cell Therapy Market, By Product
- Asia Pacific
- Asia Pacific CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Other
- Asia Pacific CAR T-cell Therapy Market, By Disease Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- Asia Pacific CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- China
- China CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
- China CAR T-cell Therapy Market, By Disease Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- China CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- China CAR T-cell Therapy Market, By Product
- Japan
- Japan CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
- Japan CAR T-cell Therapy Market, By Disease Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- Japan CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- Japan CAR T-cell Therapy Market, By Product
- Asia Pacific CAR T-cell Therapy Market, By Product
- Rest of World
- Rest of World CAR T-cell Therapy Market, By Product
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Other
- Rest of World CAR T-cell Therapy Market, By Disease Indication
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
- Rest of World CAR T-cell Therapy Market, By End Use
- Hospitals
- Cancer Treatment Centers
- Rest of World CAR T-cell Therapy Market, By Product
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2021 to 2033
- Market estimates and forecast for product segments up to 2033
- Regional market size and forecast for product segments up to 2033
- Market estimates and forecast for application segments up to 2033
- Regional market size and forecast for application segments up to 2033
- Company financial performance
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
